SGSOY

Last reported Earnings history refreshes daily; a new report appears within about 2 daysAbout this data

Next report

Feb 11 2027in 127 days

EPS estimate

$0.29

Revenue estimate

$4.86B

EPS beats

5 of last 12

EPS surprise

2021: -1.7%2022: -1.3%2022: -0.77%2023: 14.4%2023: 1.3%2024: -4.9%2024: -9.3%2025: 5.8%2025: -0.14%2026: 8.9%2026: -10.4%
Jan 27 2021Jul 24 2026
ReportedEPS estEPS actualSurpriseRevenue estRevenue actualSurprise
Jul 24 2026$0.22$0.19-10.4%$4.57B$4.51B-1.5%
Feb 11 2026$0.25$0.27+8.9%$4.42B$4.53B+2.5%
Jul 25 2025$0.22$0.22-0.1%$4.23B$4.30B+1.5%
Feb 11 2025$0.21$0.22+5.8%$3.86B$3.82B-1.0%
Jul 24 2024$0.18$0.16-9.3%$3.68B$3.77B+2.5%
Jan 26 2024$0.22$0.21-4.9%$3.95B$3.86B-2.4%
Jul 24 2023$0.19$0.19+1.3%$3.66B$3.79B+3.6%
Jan 25 2023$0.19$0.22+14.4%$3.67B$3.67B-0.1%
Jul 18 2022$0.17$0.17-0.8%$3.38B$3.36B-0.6%
Jan 27 2022$0.22$0.21-1.3%$3.59B$3.58B-0.3%
Jul 18 2021$0.16$0.16-1.7%$3.32B$3.37B+1.5%
Jan 27 2021$0.54$0.56+3.0%$3.34B$3.30B-1.1%

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+7.01%
EPS+9.63%
FY2028
Rev+6.03%
EPS+8.06%
FY2029
Rev+7.35%
EPS+7.06%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029E
Revenue Avg$7.34B$7.85B$8.33B$8.94B
Low$7.25B$7.80B$8.16B$8.76B
High$7.42B$7.90B$8.52B$9.15B
EBITDA Avg$1.62B$1.71B$1.80B$1.89B
Low$1.59B$1.69B$1.76B$1.85B
High$1.65B$1.75B$1.84B$1.93B
EBIT Avg$1.18B$1.29B$1.39B$1.48B
Low$1.15B$1.27B$1.35B$1.44B
High$1.22B$1.33B$1.43B$1.52B
Net Income Avg$761M$834M$902M$965M
Low$741M$820M$878M$939M
High$784M$859M$929M$994M
EPS Avg$0.39$0.43$0.47$0.50
Low$0.38$0.42$0.45$0.49
High$0.41$0.45$0.48$0.52
Analysts (Rev / EPS)10 / 110 / 14 / 15 / 1
Quarterly
MetricQ4 2026
Revenue Avg$2.03B
Low$2.03B
High$2.04B
EBITDA Avg—
Low—
High—
EBIT Avg—
Low—
High—
Net Income Avg—
Low—
High—
EPS Avg—
Low—
High—
Analysts (Rev / EPS)2 / —
AI Earnings SummaryQ2 2026
Checking for summary...
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.